Clinical trial
The Incidence of Pancreatic Exocrine Insufficiency and the Benefits of Pancreatic Enzyme Supplementation in Critically Ill Adult Patients
NCT01753024 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Incidence of Pancreatic Exocrine Insufficiency and the Benefits of Pancreatic Enzyme Supplementation in Critically Ill Adult Patients
- Lead sponsor
- Shanghai 10th People's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- December 31, 2015
- Enrollment
- 362 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute renal failure, cardiac arrest, critical illness, diabetes, sepsis, shock